Q1. Could you start by giving us a brief overview of your professional background, particularly focusing on your expertise in the industry?

I bring 9 years of experience across plastics and specialty chemicals, with a strong focus on combining technical depth with commercial strategy to drive growth.

I started my career at BASF, where I worked on engineering plastics and polyurethanes while managing key automotive accounts. I then expanded into international markets at Mstack, driving exports of Indian specialty chemicals across the Asia-Pacific region.

At Vital Group, I led business development across pharma and agrochemicals, advising on CDMO opportunities and expanding the global customer base.

Currently, I lead New Business Development for the IMEA region at Lubrizol, where I focus on identifying high-impact opportunities, building strategic partnerships, and scaling specialty polymer and formulation businesses across emerging markets.

My experience has been centered on identifying scalable opportunities, driving revenue growth, and building long-term customer relationships in an evolving global chemical landscape.

 

Q2. How are demand patterns for specialty chemicals evolving differently across India vs. Middle East, and Africa? Which region is structurally outperforming, and why?

Demand is diverging structurally across these regions:

India is seeing the strongest broad-based growth, driven by domestic consumption, import substitution, and increasing localization of different chemistries & value chains.

Segments like personal care actives, construction chemicals, and specialty polymers are scaling rapidly.

Middle East is evolving from a feedstock-led economy to a downstream diversification play.

Countries like Saudi Arabia and the UAE are investing heavily in specialty and performance chemicals to move up the value chain.

Africa remains underpenetrated but high-potential. Growth is demand-led (FMCG, agriculture, infrastructure), but limited local manufacturing and fragmented distribution slow the scale.

 

Q3. How is the competitive landscape changing between large multinationals and emerging regional players, and what differentiates those that are scaling successfully?

• The gap is closing, but selectively

Multinationals still have a clear edge when it comes to high-performance chemistries, regulatory-heavy segments, and deep application development.

That said, regional players are catching up faster than before, especially in areas where speed, flexibility, and cost matter more than pure technology.

• Regional players are winning on execution

What I’m seeing on the ground is that local companies are far more agile, they move faster, price more competitively, and are better at customizing for specific customer needs.

In many cases, that matters more to customers than having the most advanced chemistry on paper, especially in the Indian market scenario where costing is still a big factor.

• The winners are combining both worlds

The companies that are really scaling, particularly in India, are those that go beyond trading or basic manufacturing. They’re investing in backward integration, building application-level capabilities, and staying very close to customers.

At the same time, there’s a clear shift happening: regional players are moving up the value chain into specialties, while MNCs are localizing production to stay competitive.

 

Q4. To what extent is the China+1 strategy translating into real, scalable opportunities for India and the Middle East in specialty chemicals?

China+1 is definitely real, but it’s not a straight or immediate shift away from China.

India is seeing tangible benefits, especially in agrochemical intermediates, pharma CDMO, and parts of the specialty polymers space.

There’s a clear intent from global customers to diversify supply chains, and India is one of the primary alternatives being considered.

That said, scaling remains the key challenge. Cost competitiveness is still difficult to match, China’s advantage comes from decades of backward integration, strong raw material ecosystems, and sheer economies of scale.

That creates a systemic edge which is not easy to replicate quickly.

The Middle East is also moving downstream, but in a more targeted way. Companies like SABIC and ADNOC are leveraging low-cost hydrocarbons to expand into derivatives and select specialty chemicals.

However, this is largely focused on petrochemical-linked value chains rather than building a broad, China-like manufacturing ecosystem.

The way I see it, this is less about replacing China and more about reshaping supply chains. 

China will remain central, but its share will gradually dilute as India captures more chemistry-led opportunities and the Middle East builds strength in feedstock-linked specialties.

The real winners will be those who can scale reliably and move up the value chain because that’s where the shift is actually happening.

 

Q5. What has your experience been with sustainability-led solutions translating into actual business opportunities, and how are customers responding to these shifts?

Sustainability is moving beyond just a narrative, but it’s still very selective in how it converts into real business.

Customers are interested, but highly price-sensitive. Adoption typically happens when there’s a regulatory push specially when catering to export markets like the EU or US or when there’s a clear performance benefit.

We’re seeing traction in areas like water-based and low-VOC coatings, bio-based ingredients in personal care, recyclable packaging, and green solvents in pharma.

In price-sensitive markets like India and Africa, sustainability alone doesn’t drive decisions, it has to come with cost parity or better performance.

 

Q6. How is digitalization—whether in formulation, customer engagement, or demand planning—changing the way specialty chemical companies create and capture value?

Digitalization is quietly becoming a real differentiator in specialty chemicals.

We’re seeing faster formulation and development cycles through simulation tools, more effective customer engagement via CRM-led selling, and better demand planning with data-driven forecasting, especially important given raw material volatility.

What’s really changing is the shift from just selling products to offering solutions backed by data.

AI is accelerating this further helping companies predict demand, optimize formulations, and respond faster in a very volatile, VUCA environment.

The ones that combine digital tools with strong application understanding will clearly have an edge.

 

Q7. If you were an investor looking at companies within the space, what critical question would you pose to their senior management?

"What is your real right to win and how sustainable is it over the next 5-10 years?"

From there, it comes down to a few practical things. Is the business built on genuine technology or just capacity?

How sticky are the customers, are they embedded in formulations and approvals, or easy to replace? And importantly, can the company scale without giving up margins?

In this space, long-term value doesn’t come from just pushing volumes. It comes from consistency, high switching costs, and how deeply you’re integrated into the customer’s application.